Omnipaque 350 mg/mL (Iohexol INJECTION, SOLUTION) 350 mg/mL

Omnipaque 350 mg/mL is an injectable solution containing iohexol, used for diagnostic imaging procedures. This contrast agent enhances visibility during X-rays and CT scans, aiding in accurate medical assessments.

Strength

350 mg/mL

Pack Size

10 BOTTLE, PLASTIC in 1 BOX (0407-1414-93) / 150 mL in 1 BOTTLE, PLASTIC

Manufacturer / TM Owner

GE Healthcare

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Omnipaque 350 mg/mL is primarily used as a contrast medium for various diagnostic imaging techniques. It is commonly administered intravenously to improve the clarity of X-rays and CT scans, helping healthcare professionals visualize internal structures more effectively. This contrast agent is often utilized in procedures where detailed imaging is required, such as angiography or myelography.

Side Effects

When administered, Omnipaque 350 mg/mL may cause a temporary warming sensation or a metallic taste in the mouth. Some individuals might experience mild nausea or a feeling of warmth during the procedure. These effects are generally short-lived and subside quickly.

Precautions & Warnings

Omnipaque 350 mg/mL should be used with caution in individuals with a history of allergic reactions to contrast agents. It is important to inform healthcare providers about any existing medical conditions or allergies before administration. Proper handling and storage are essential to maintain the integrity of the solution.

Avoid Interactions

Omnipaque 350 mg/mL may interact with certain medications or substances, including other contrast agents or drugs that affect kidney function. It is advisable to consult with a healthcare provider regarding potential interactions, especially if taking other medications or supplements.

Frequently Asked Questions

Omnipaque 350 mg/mL is used as a contrast agent to enhance the visibility of internal structures during diagnostic imaging procedures such as X-rays and CT scans.

Omnipaque 350 mg/mL is administered intravenously by a healthcare professional during imaging procedures.

Common effects may include a temporary warming sensation, metallic taste, or mild nausea, which typically subside quickly.

Precautions include informing healthcare providers about allergies or medical conditions, and ensuring proper handling and storage of the solution.

Potential interactions may occur with other contrast agents or drugs affecting kidney function, so consulting a healthcare provider is advisable.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.